Innoviva Inc reports results for the quarter ended in December - Earnings Summary

Innoviva

29/02/2024 22:24

* Innoviva Inc  INVA.OQ  reported quarterly adjusted
earnings of
76 cents​​ per share for the quarter ended in December, higher
than the same quarter last year, when the company reported EPS
of -98 cents.  The lone analyst forecast for the quarter was
for earnings of 23 cents per share. 
    * Revenue rose 30.4% to $85.84 million from a year ago;
analysts
expected $75.52 million. 
    * Innoviva Inc shares had fallen by 4.3% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "hold"

Wall Street's median 12-month price target for Innoviva Inc is
$15.00 
This summary was machine generated from LSEG data February 29 at
10:23 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      0.23           0.76           Beat
 Sep. 30 2023      0.27           0.98           Beat
 Jun. 30 2023      0.26           0.02           Missed
 Mar. 31 2023      0.23           0.42           Beat